Ethanol-TGFα-MEK Signaling Promotes Growth of Human Hepatocellular Carcinoma

Journal of Surgical Research

Volumn 154, Issue 2, 2009, Pages 187-195

  Hennig, Matthew ^a   Yip Schneider, Michele T ^a   Klein, Patrick ^a   Wentz, Sabrina ^a   Matos, Jesus M ^a   Doyle, Courtney ^a   Choi, Jennifer ^a   Wu, Huangbing ^a   O'Mara, Amanda ^a   Menze, Alex ^a   Noble, Stephen ^a   McKillop, Iain H ^b   Schmidt, C Max ^a,c,d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

ERK; ethanol; HCC; hepatocellular carcinoma; MEK; TGF

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ALCOHOL; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; 1,3 BUTADIENE DERIVATIVE; ANTIBODY; CENTRAL DEPRESSANT AGENT; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; NITRILE; PROTEIN KINASE B;

ALCOHOL METABOLISM; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR PROMOTION; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIBODIES; BUTADIENES; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CELL LINE, TUMOR; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ENZYME INHIBITORS; ETHANOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; LIVER NEOPLASMS; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; NITRILES; PROTO-ONCOGENE PROTEINS C-AKT; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 67349141271     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.11.836     Document Type: Article

References (48)

1. Bosch F.X., Ribes J., Cleries R., et al. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9 (2005) 191
2. El-Serag H.B. Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology 127 (2004) S27
3. McKillop I.H., and Schrum L.W. Alcohol and liver cancer. Alcohol 35 (2005) 195
4. Okuda K. Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants. J Gastroenterol Hepatol 17 (2002) 401
5. Longnecker M.P. Alcohol consumption and risk of cancer in humans: An overview. Alcohol 12 (1995) 87
6. Kew M.C. Epidemiology of hepatocellular carcinoma. Toxicology 35 (2002) 181
7. Smart R.G., Mann R.E., and Suurvali H. Changes in liver cirrhosis death rates in different countries in relation to per capita alcohol consumption and Alcoholics Anonymous membership. J Stud Alcohol 59 (1998) 245
8. Stickel F., Schuppan D., Hahn E.G., and Seitz H.K. Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut 51 (2002) 132
9. Colombo M., and Sangiovanni A. Etiology, natural history and treatment of hepatocellular carcinoma. Antiviral Res 60 (2003) 145
10. Hoek J.B., and Pastorino J.G. Cellular signaling mechanisms in alcohol-induced liver damage. Semin Liver Dis 24 (2004) 257
11. Chang L., and Karin M. Mammalian MAP kinase signalling cascades. Nature 410 (2001) 37
12. Garrington T.P., and Johnson G.L. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 11 (1999) 211
13. Matozaki T., Nakanishi H., and Takai Y. Small G-protein networks: Their crosstalk and signal cascades. Cell Signal 12 (2000) 515
14. McKillop I.H., Schmidt C.M., Cahill P.A., et al. Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma. Hepatology 26 (1997) 1484
15. Schmidt C.M., McKillop I.H., Cahill P.A., et al. Increased MAPK expression and activity in primary human hepatocellular carcinoma. Biochem Biophys Res Commun 236 (1997) 54
16. Gutierrez-Ruiz M.C., Quiroz S.C., Souza V., et al. Cytokines, growth factors, and oxidative stress in HepG2 cells treated with ethanol, acetaldehyde, and LPS. Toxicology 134 (1999) 197
17. Jeong H.J., Hong S.H., Park R.K., et al. Ethanol induces the production of cytokines via the Ca2+, MAP kinase, HIF-1alpha, and NF-kappaB pathway. Life Sci 77 (2005) 2179
18. Kato J., Sato Y., Inui N., et al. Ethanol induces transforming growth factor-alpha expression in hepatocytes, leading to stimulation of collagen synthesis by hepatic stellate cells. Alcohol Clin Exp Res 27 (2003) 58S
19. McClain C.J., Shedlofsky S., Barve S., et al. Cytokines and alcoholic liver disease. Alcohol Health Res World 21 (1997) 317
20. Clemens D.L., Halgard C.M., Miles R.R., et al. Establishment of a recombinant hepatic cell line stably expressing alcohol dehydrogenase. Arch Biochem Biophys 321 (1995) 311
21. Higuchi H., and Gores G.J. Mechanisms of liver injury: An overview. Curr Mol Med 3 (2003) 483
22. Morgan T.R., Mandayam S., and Jamal M.M. Alcohol and hepatocellular carcinoma. Gastroenterology 127 (2004) S87
23. Seger R., and Krebs E.G. The MAPK signaling cascade. Faseb J 9 (1995) 726
24. Kawamura K., Fukuda J., Shimizu Y., et al. Survivin contributes to the anti-apoptotic activities of transforming growth factor alpha in mouse blastocysts through phosphatidylinositol 3'-kinase pathway. Biol Reprod 73 (2005) 1094
25. Sewell J.M., Smyth J.F., and Langdon S.P. Role of TGF alpha stimulation of the ERK, PI3 kinase and PLC gamma pathways in ovarian cancer growth and migration. Exp Cell Res 304 (2005) 305
26. Feo F., Pascale R.M., Simile M.M., et al. Genetic alterations in liver carcinogenesis: Implications for new preventive and therapeutic strategies. Crit Rev Oncog 11 (2000) 19
27. Ito Y., Sasaki Y., Horimoto M., et al. Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma. Hepatology 27 (1998) 951
28. Wiesenauer C.A., Yip-Schneider M.T., Wang Y., et al. Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma. J Am Coll Surg 198 (2004) 410
29. Aroor A.R., and Shukla S.D. MAP kinase signaling in diverse effects of ethanol. Life Sci 74 (2004) 2339
30. Reddy M.A., and Shukla S.D. Potentiation of mitogen-activated protein kinase by ethanol in embryonic liver cells. Biochem Pharmacol 51 (1996) 661
31. McKillop I.H., Vyas N., Schmidt C.M., et al. Enhanced Gi-protein-mediated mitogenesis following chronic ethanol exposure in a rat model of experimental hepatocellular carcinoma. Hepatology 29 (1999) 412
32. Thoresen G.H., Guren T.K., Sandnes D., et al. Response to transforming growth factor alpha (TGFalpha) and epidermal growth factor (EGF) in hepatocytes: Lower EGF receptor affinity of TGFalpha is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater efficacy in stimulation of DNA synthesis. J Cell Physiol 175 (1998) 10
33. Zhang J., Wang W.L., Li Q., et al. Expression of transforming growth factor-alpha and hepatitis B surface antigen in human hepatocellular carcinoma tissues and its significance. World J Gastroenterol 10 (2004) 830
34. Hufnagl K., Parzefall W., Marian B., et al. Role of transforming growth factor alpha and prostaglandins in preferential growth of preneoplastic rat hepatocytes. Carcinogenesis 22 (2001) 1247
35. Kira S., Nakanishi T., Suemori S., et al. Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma. Liver 17 (1997) 177
36. Chung Y.H., Kim J.A., Song B.C., et al. Expression of transforming growth factor-alpha mRNA in livers of patients with chronic viral hepatitis and hepatocellular carcinoma. Cancer 89 (2000) 977
37. Hayashi J., Aoki H., Kajino K., et al. Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha. Hepatology 32 (2000) 958
38. Tuma D.J., Todero S.L., Barak-Bernhagen M., et al. Effects of chronic ethanol administration on the endocytosis of cytokines by rat hepatocytes. Alcohol Clin Exp Res 20 (1996) 579
39. Wu J.C., Merlino G., and Fausto N. Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proc Natl Acad Sci U S A 91 (1994) 674
40. Washington B., Mtshali C., Williams S., et al. Ethanol-induced mitogen activated protein kinase activity mediated through protein kinase C. Cell Mol Biol (Noisy-le-grand) 49 (2003) 1351
41. Doraiswamy V., Parrott J.A., and Skinner M.K. Expression and action of transforming growth factor alpha in normal ovarian surface epithelium and ovarian cancer. Biol Reprod 63 (2000) 789
42. More E., Fellner T., Doppelmayr H., et al. Activation of the MAP kinase pathway induces chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) expression in human breast cancer cell lines. J Endocrinol 176 (2003) 83
43. Piyathilake C.J., Frost A.R., Manne U., et al. Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung. Clin Cancer Res 8 (2002) 734
44. Sawhney R.S., Sharma B., Humphrey L.E., et al. Integrin alpha2 and extracellular signal-regulated kinase are functionally linked in highly malignant autocrine transforming growth factor-alpha-driven colon cancer cells. J Biol Chem 278 (2003) 19861
45. Vail M.E., Pierce R.H., and Fausto N. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha. Cancer Res 61 (2001) 594
46. Wu M., Putti T.C., and Bhuiya T.A. Comparative study in the expression of p53, EGFR, TGF-alpha, and cyclin D1 in verrucous carcinoma, verrucous hyperplasia, and squamous cell carcinoma of head and neck region. Appl Immunohistochem Mol Morphol 10 (2002) 351
47. Zhou R., and Skalli O. Identification of cadherin-11 down-regulation as a common response of astrocytoma cells to transforming growth factor-alpha. Differentiation 66 (2000) 165
48. Boyle P., Macfarlane G.J., Blot W.J., et al. European School of Oncology Advisory report to the European Commission for the Europe Against Cancer Programme: Oral carcinogenesis in Europe. Eur J Cancer B Oral Oncol 31B (1995) 75